US Stock MarketDetailed Quotes
RLAY Relay Therapeutics
- 5.105
- -0.495-8.84%
Close Nov 15 16:00 ET
- 5.160
- +0.055+1.08%
Post 20:01 ET
854.49MMarket Cap-1955P/E (TTM)
5.630High5.030Low1.93MVolume5.630Open5.600Pre Close9.91MTurnover1.51%Turnover RatioLossP/E (Static)167.38MShares12.14052wk High1.02P/B650.12MFloat Cap5.03052wk Low--Dividend TTM127.35MShs Float64.370Historical High--Div YieldTTM10.71%Amplitude5.030Historical Low5.145Avg Price1Lot Size
Relay Therapeutics Key Stats
EPS
According to the latest financial report of Relay Therapeutics, the latest earnings per share (TTM) for the company is -0.63. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Relay Therapeutics's free cash flow? The latest report shows it as -75.31M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Relay Therapeutics shows that the company's current ratio is 18.42, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Relay Therapeutics, the quick ratio is 17.88, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Relay Therapeutics? The latest ROE figure is -11.59%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Relay Therapeutics, the total asset return on investment (ROA) is -10.35%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Relay Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Relay Therapeutics, the net profit margin is -813.30%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data